MiR-106a targets ATG7 to inhibit autophagy and angiogenesis after myocardial infarction.
Guofeng BaiJinghao YangWeili LiaoXiaofeng ZhouYingting HeNian LiLiuhong ZhangYifei WangXiaoli DongHao ZhangJinchun PanLiangxue LaiXiaolong YuanXilong WangPublished in: Animal models and experimental medicine (2024)
Our results indicate that miR-106a may inhibit autophagy and angiogenesis by targeting ATG7. This mechanism may be a potential therapeutic treatment for MI.